{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:41:28Z","timestamp":1778798488293,"version":"3.51.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institute on Drug Abuse\/National Institute on Alcohol Abuse and Alcoholism","award":["ZIA-DA000635"],"award-info":[{"award-number":["ZIA-DA000635"]}]},{"name":"National Institute on Drug Abuse\/National Institute on Alcohol Abuse and Alcoholism","award":["ZIA-DA000644"],"award-info":[{"award-number":["ZIA-DA000644"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07035-6","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T02:53:12Z","timestamp":1772419992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dissecting the role of mineralocorticoid receptors in binge-like alcohol drinking in mice: Finerenone as a potential pharmacotherapy"],"prefix":"10.1007","author":[{"given":"Courtney S.","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"VI","given":"Nicolaus","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire L.","family":"Pince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Adrienne","family":"McGinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Farokhnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro F.","family":"Vendruscolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"2","key":"7035_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/ckj\/sfac234","volume":"16","author":"R Agarwal","year":"2023","unstructured":"Agarwal R, Pitt B, Palmer BF, Kovesdy CP, Burgess E, Filippatos G, Ma\u0142yszko J, Ruilope LM, Rossignol P, Rossing P, Pecoits-Filho R, Anker SD, Joseph A, Lawatscheck R, Wilson D, Gebel M, Bakris GL (2023) A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease. Clin Kidney J 16(2):293\u2013302. https:\/\/doi.org\/10.1093\/ckj\/sfac234","journal-title":"Clin Kidney J"},{"issue":"5","key":"7035_CR2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1161\/01.HYP.35.5.1099","volume":"35","author":"R Alzamora","year":"2000","unstructured":"Alzamora R, Michea L, Marusic ET (2000) Role of 11\u03b2-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension 35(5):1099\u20131104. https:\/\/doi.org\/10.1161\/01.HYP.35.5.1099","journal-title":"Hypertension"},{"issue":"6","key":"7035_CR3","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/mp.2017.97","volume":"23","author":"EG Aoun","year":"2018","unstructured":"Aoun EG, Jimenez VA, Vendruscolo LF, Walter NAR, Barbier E, Ferrulli A, Haass-Koffler CL, Darakjian P, Lee MR, Addolorato G, Heilig M, Hitzemann R, Koob GF, Grant KA, Leggio L (2018) A relationship between the aldosterone-mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans. Mol Psychiatry 23(6):1466\u20131473. https:\/\/doi.org\/10.1038\/mp.2017.97","journal-title":"Mol Psychiatry"},{"key":"7035_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1384454","volume":"11","author":"M Arici","year":"2024","unstructured":"Arici M, Altun B, Araz M, Atmaca A, Demir T, Ecder T, Guz G, Gogas Yavuz D, Yildiz A, Yilmaz T (2024) The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials. Front Med (Lausanne) 11:1384454. https:\/\/doi.org\/10.3389\/fmed.2024.1384454","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"7035_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1042\/cs0660659","volume":"66","author":"LT Bannan","year":"1984","unstructured":"Bannan LT, Potter JF, Beevers DG, Saunders JB, Walters JR, Ingram MC (1984) Effect of alcohol withdrawal on blood pressure, plasma renin activity, aldosterone, cortisol and dopamine beta-hydroxylase. Clin Sci (Lond) 66(6):659\u2013663. https:\/\/doi.org\/10.1042\/cs0660659","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"7035_CR6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1042\/bj3131007","volume":"313","author":"RW Brown","year":"1996","unstructured":"Brown RW, Chapman KE, Kotelevtsev Y, Yau JLW, Lindsay RS, Brett L, Leckie C, Murad P, Lyons V, Mullins JJ, Edwards CRW, Seckl JR (1996) Cloning and production of antisera to human placental 11 \u03b2-hydroxysteroid dehydrogenase type 2. Biochem J 313(3):1007\u20131017. https:\/\/doi.org\/10.1042\/bj3131007","journal-title":"Biochem J"},{"issue":"4","key":"7035_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000125250","volume":"50","author":"HM Chao","year":"1989","unstructured":"Chao HM, Choo PH, McEwen BS (1989) Glucocorticoid and mineralocorticoid receptor mRNA expression in rat brain. Neuroendocrinology 50(4):365\u2013371. https:\/\/doi.org\/10.1159\/000125250","journal-title":"Neuroendocrinology"},{"issue":"2","key":"7035_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/08998280.2004.11927973","volume":"17","author":"J Craft","year":"2004","unstructured":"Craft J (2004) Eplerenone (Inspra), a new aldosterone antagonist for the treatment of systemic hypertension and heart failure. Proceedings (Baylor University. Medical Center) 17(2):217\u2013220. https:\/\/doi.org\/10.1080\/08998280.2004.11927973","journal-title":"Proceedings (Baylor University. Medical Center)"},{"issue":"2","key":"7035_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","volume":"240","author":"M de Gasparo","year":"1987","unstructured":"de Gasparo M, Joss U, Ramjou\u00e9 HP, Whitebread SE, Haenni H, Schenkel L, Kraehenbuehl C, Biollaz M, Grob J, Schmidlin J (1987) Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro. J Pharmacol Exp Ther 240(2):650\u2013656","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"7035_CR10","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1046\/j.1523-1755.2000.00971.x","volume":"57","author":"ER de Kloet","year":"2000","unstructured":"de Kloet ER, Van Acker SA, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K, de Jong W (2000) Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 57(4):1329\u20131336. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00971.x","journal-title":"Kidney Int"},{"key":"7035_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2024.112389","volume":"594","author":"D de la Alvarez Rosa","year":"2024","unstructured":"de la Rosa DA, Ramos-Hern\u00e1ndez Z, Weller-P\u00e9rez J, Johnson TA, Hager GL (2024) The impact of mineralocorticoid and glucocorticoid receptor interaction on corticosteroid transcriptional outcomes. Mol Cell Endocrinol 594:112389. https:\/\/doi.org\/10.1016\/j.mce.2024.112389","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"7035_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12123992","volume":"12","author":"L Di Lullo","year":"2023","unstructured":"Di Lullo L, Lavalle C, Scatena A, Mariani MV, Ronco C, Bellasi A (2023) Finerenone: questions and answers\u2014the four fundamental arguments on the new-born promising non-steroidal mineralocorticoid receptor antagonist. J Clin Med 12(12):3992","journal-title":"J Clin Med"},{"issue":"5","key":"7035_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/01.Alc.0000065433.17403.De","volume":"27","author":"WK D\u00f6ring","year":"2003","unstructured":"D\u00f6ring WK, Herzenstiel MN, Krampe H, Jahn H, Pralle L, Sieg S, Wegerle E, Poser W, Ehrenreich H (2003) Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics. Alcohol Clin Exp Res 27(5):849\u2013861. https:\/\/doi.org\/10.1097\/01.Alc.0000065433.17403.De","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"7035_CR14","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00213-019-5168-9","volume":"236","author":"BL Dozier","year":"2019","unstructured":"Dozier BL, Stull CA, Baker EJ, Ford MM, Jensen JP, Finn DA, Grant KA (2019) Chronic ethanol drinking increases during the luteal menstrual cycle phase in rhesus monkeys: implication of progesterone and related neurosteroids. Psychopharmacology 236(6):1817\u20131828. https:\/\/doi.org\/10.1007\/s00213-019-5168-9","journal-title":"Psychopharmacology"},{"issue":"10","key":"7035_CR15","first-page":"88","volume":"68","author":"LF Fabre","year":"1972","unstructured":"Fabre LF, Howard PY, Farmer RW (1972) Endocrine abnormalities in male alcoholic subjects. Tex Med 68(10):88\u201393","journal-title":"Tex Med"},{"key":"7035_CR16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1749-6632.1973.tb28288.x","volume":"215","author":"LF Fabre","year":"1973","unstructured":"Fabre LF, Farmer RW, Roach MK, Fritchie GE, McIsaac WM (1973) Biochemical and metabolic aspects of alcoholism. Ann N Y Acad Sci 215:346\u2013355. https:\/\/doi.org\/10.1111\/j.1749-6632.1973.tb28288.x","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"7035_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0741-8329(94)90031-0","volume":"11","author":"C Fahlke","year":"1994","unstructured":"Fahlke C, Engel JA, Eriksson CJ, H\u00e5rd E, S\u00f6derpalm B (1994) Involvement of corticosterone in the modulation of ethanol consumption in the rat. Alcohol 11(3):195\u2013202. https:\/\/doi.org\/10.1016\/0741-8329(94)90031-0","journal-title":"Alcohol"},{"issue":"2","key":"7035_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/bf02245190","volume":"117","author":"C Fahlke","year":"1995","unstructured":"Fahlke C, H\u00e5rd E, Eriksson CJ, Engel JA, Hansen S (1995) Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists. Psychopharmacology 117(2):216\u2013224. https:\/\/doi.org\/10.1007\/bf02245190","journal-title":"Psychopharmacology"},{"issue":"6","key":"7035_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/alcalc\/34.6.851","volume":"34","author":"C Fahlke","year":"1999","unstructured":"Fahlke C, Hansen S (1999) Effect of local intracerebral corticosterone implants on alcohol intake in the rat. Alcohol Alcohol 34(6):851\u2013861. https:\/\/doi.org\/10.1093\/alcalc\/34.6.851","journal-title":"Alcohol Alcohol"},{"key":"7035_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-1-4684-7529-6_14","volume":"56","author":"RW Farmer","year":"1975","unstructured":"Farmer RW, Fabre LF (1975) Some endocrine aspects of alcoholism. Adv Exp Med Biol 56:277\u2013289. https:\/\/doi.org\/10.1007\/978-1-4684-7529-6_14","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"7035_CR21","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1038\/s41380-022-01736-y","volume":"27","author":"M Farokhnia","year":"2022","unstructured":"Farokhnia M, Rentsch CT, Chuong V, McGinn MA, Elvig SK, Douglass EA, Gonzalez LA, Sanfilippo JE, Marchette RCN, Tunstall BJ, Fiellin DA, Koob GF, Justice AC, Leggio L, Vendruscolo LF (2022) Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies. Mol Psychiatry 27(11):4642\u20134652. https:\/\/doi.org\/10.1038\/s41380-022-01736-y","journal-title":"Mol Psychiatry"},{"issue":"2","key":"7035_CR22","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1111\/ejn.15691","volume":"56","author":"J Forstenpointner","year":"2022","unstructured":"Forstenpointner J, Maallo AMS, Elman I, Holmes S, Freeman R, Baron R, Borsook D (2022) The solitary nucleus connectivity to key autonomic regions in humans. Eur J Neurosci 56(2):3938\u20133966. https:\/\/doi.org\/10.1111\/ejn.15691","journal-title":"Eur J Neurosci"},{"issue":"6","key":"7035_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","volume":"46","author":"PJ Fuller","year":"2005","unstructured":"Fuller PJ, Young MJ (2005) Mechanisms of mineralocorticoid action. Hypertension 46(6):1227\u20131235. https:\/\/doi.org\/10.1161\/01.HYP.0000193502.77417.17","journal-title":"Hypertension"},{"issue":"4","key":"7035_CR24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/cne.21019","volume":"497","author":"JC Geerling","year":"2006","unstructured":"Geerling JC, Loewy AD (2006) Aldosterone-sensitive neurons in the nucleus of the solitary tract: bidirectional connections with the central nucleus of the amygdala. J Comp Neurol 497(4):646\u2013657. https:\/\/doi.org\/10.1002\/cne.21019","journal-title":"J Comp Neurol"},{"issue":"5","key":"7035_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tem.2011.02.001","volume":"22","author":"EP Gomez-Sanchez","year":"2011","unstructured":"Gomez-Sanchez EP (2011) Mineralocorticoid receptors in the brain and cardiovascular regulation: Minority rule? Trends Endocrinol Metab 22(5):179\u2013187. https:\/\/doi.org\/10.1016\/j.tem.2011.02.001","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"7035_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/fjc.0000000000000329","volume":"67","author":"EP Gomez-Sanchez","year":"2016","unstructured":"Gomez-Sanchez EP (2016) Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth? J Cardiovasc Pharmacol 67(1):26\u201338. https:\/\/doi.org\/10.1097\/fjc.0000000000000329","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"7035_CR27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/cphy.c130044","volume":"4","author":"E Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez E, Gomez-Sanchez CE (2014) The multifaceted mineralocorticoid receptor. Compr Physiol 4(3):965\u2013994. https:\/\/doi.org\/10.1002\/cphy.c130044","journal-title":"Compr Physiol"},{"issue":"4","key":"7035_CR28","doi-asserted-by":"publisher","first-page":"F699","DOI":"10.1152\/ajprenal.00133.2002","volume":"283","author":"DW Good","year":"2002","unstructured":"Good DW, George T, Watts BA (2002) Aldosterone inhibits HCO-3 absorption via a nongenomic pathway in medullary thick ascending limb. Am J Physiology-Renal Physiol 283(4):F699\u2013F706. https:\/\/doi.org\/10.1152\/ajprenal.00133.2002","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"4","key":"7035_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/CIRCRESAHA.117.312380","volume":"122","author":"ME Good","year":"2018","unstructured":"Good ME, Chiu YH, Poon IKH, Medina CB, Butcher JT, Mendu SK, DeLalio LJ, Lohman AW, Leitinger N, Barrett E, Lorenz UM, Desai BN, Jaffe IZ, Bayliss DA, Isakson BE, Ravichandran KS (2018) Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone. Circ Res 122(4):606\u2013615. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.312380","journal-title":"Circ Res"},{"issue":"1","key":"7035_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2009.02.005","volume":"308","author":"C Grossmann","year":"2009","unstructured":"Grossmann C, Gekle M (2009) New aspects of rapid aldosterone signaling. Mol Cell Endocrinol 308(1):53\u201362. https:\/\/doi.org\/https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.mce.2009.02.005","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"7035_CR31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/hypertensionaha.117.10360","volume":"71","author":"J Grune","year":"2018","unstructured":"Grune J, Beyhoff N, Smeir E, Chudek R, Blumrich A, Ban Z, Brix S, Betz IR, Schupp M, Foryst-Ludwig A, Klopfleisch R, Stawowy P, Houtman R, Kolkhof P, Kintscher U (2018) Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone\u2019s Antifibrotic Activity. Hypertension 71(4):599\u2013608. https:\/\/doi.org\/10.1161\/hypertensionaha.117.10360","journal-title":"Hypertension"},{"key":"7035_CR32","first-page":"421","volume":"1","author":"LA Grupp","year":"1991","unstructured":"Grupp LA (1991) The renin-angiotensin system: A multidimensional source of control over alcohol consumption. Alcohol Alcohol Suppl 1:421\u2013426","journal-title":"Alcohol Alcohol Suppl"},{"issue":"1","key":"7035_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/BF00431771","volume":"87","author":"LA Grupp","year":"1985","unstructured":"Grupp LA, Elias J, Perlanski E, Stewart RB (1985) Modification of ethanol-induced motor impairment by diet, diuretic, mineralocorticoid, or prostaglandin synthetase inhibitor. Psychopharmacology 87(1):20\u201324. https:\/\/doi.org\/10.1007\/BF00431771","journal-title":"Psychopharmacology"},{"issue":"2","key":"7035_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0149-7634(05)80006-5","volume":"15","author":"LA Grupp","year":"1991","unstructured":"Grupp LA, Perlanski E, Stewart RB (1991) Regulation of alcohol consumption by the renin-angiotensin system: a review of recent findings and a possible mechanism of action. Neurosci Biobehav Rev 15(2):265\u2013275. https:\/\/doi.org\/10.1016\/S0149-7634(05)80006-5","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"7035_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00213-006-0646-2","volume":"191","author":"K Hefner","year":"2007","unstructured":"Hefner K, Holmes A (2007) An investigation of the behavioral actions of ethanol across adolescence in mice. Psychopharmacology (Berl) 191(2):311\u2013322. https:\/\/doi.org\/10.1007\/s00213-006-0646-2","journal-title":"Psychopharmacology (Berl)"},{"key":"7035_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1176\/appi.ajp.20230027","volume":"181","author":"S Hoffmann","year":"2024","unstructured":"Hoffmann S, Gerhardt S, M\u00fchle C, Reinhard I, Reichert D, Bach P, Boroumand-Jazi R, Kuehner C, Aguilera A, Aslan A, Bahr NS, Belanger M, Deeken F, Ebrahimi C, Fischbach PC, Ganz M, Garbusow M, Gro\u00dfkopf CM, Heigert M, ReCoDe Consortium (2024) Associations of Menstrual Cycle and Progesterone-to-Estradiol Ratio With Alcohol Consumption in Alcohol Use Disorder: A Sex-Separated Multicenter Longitudinal Study. Am J Psychiatry 181:445\u2013456. https:\/\/doi.org\/10.1176\/appi.ajp.20230027","journal-title":"Am J Psychiatry"},{"issue":"12","key":"7035_CR37","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1111\/acer.15470","volume":"48","author":"R Hornbacher","year":"2024","unstructured":"Hornbacher R, Gully BJ, Brown ZE, Brown JC, Magill M, Cioe PA, Swift RM, Sanna PP, Haass-Koffler CL (2024) Probenecid as a pharmacotherapy for alcohol use disorder: a randomized placebo-controlled alcohol interaction trial. Alcohol Clin Exp Res (Hoboken) 48(12):2391\u20132403. https:\/\/doi.org\/10.1111\/acer.15470","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"issue":"6","key":"7035_CR38","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1210\/me.2004-0537","volume":"19","author":"ML Hultman","year":"2005","unstructured":"Hultman ML, Krasnoperova NV, Li S, Du S, Xia C, Dietz JD, Lala DS, Welsch DJ, Hu X (2005) The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms. Mol Endocrinol 19(6):1460\u20131473. https:\/\/doi.org\/10.1210\/me.2004-0537","journal-title":"Mol Endocrinol"},{"key":"7035_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00260","volume":"9","author":"VA Jimenez","year":"2015","unstructured":"Jimenez VA, Helms CM, Cornea A, Meshul CK, Grant KA (2015) An ultrastructural analysis of the effects of ethanol self-administration on the hypothalamic paraventricular nucleus in rhesus macaques. Front Cell Neurosci 9:260. https:\/\/doi.org\/10.3389\/fncel.2015.00260","journal-title":"Front Cell Neurosci"},{"key":"7035_CR40","doi-asserted-by":"publisher","first-page":"S553","DOI":"10.1016\/S0924-977X(13)70880-0","volume":"23","author":"V Kashkin","year":"2013","unstructured":"Kashkin V, Shekunova E, Bagrov Y, Bagrov A (2013) Spironolactone suppresses ethanol-seeking behavior and relapse in rats. Eur Neuropsychopharmacol 23:S553\u2013S554. https:\/\/doi.org\/10.1016\/S0924-977X(13)70880-0","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"7035_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1573402114666180212115518","volume":"14","author":"VA Kashkin","year":"2018","unstructured":"Kashkin VA, Shekunova EV, Egorov AY, Bagrov AY (2018) Marinobufagenin in urine: a potential marker of predisposition to ethanol and a target for spironolactone. Curr Hypertens Rev 14(1):35\u201338. https:\/\/doi.org\/10.2174\/1573402114666180212115518","journal-title":"Curr Hypertens Rev"},{"key":"7035_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2023.109291","volume":"199","author":"D Koca","year":"2023","unstructured":"Koca D, Lother A (2023) Molecular pharmacology of mineralocorticoid receptor antagonists: the role of co-regulators. Steroids 199:109291. https:\/\/doi.org\/10.1016\/j.steroids.2023.109291","journal-title":"Steroids"},{"issue":"1","key":"7035_CR43","doi-asserted-by":"publisher","first-page":"T125","DOI":"10.1530\/JOE-16-0600","volume":"234","author":"P Kolkhof","year":"2017","unstructured":"Kolkhof P, Barfacker L (2017) 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development. J Endocrinol 234(1):T125\u2013T140. https:\/\/doi.org\/10.1530\/JOE-16-0600","journal-title":"J Endocrinol"},{"key":"7035_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2023.102359","volume":"69","author":"M Koval","year":"2023","unstructured":"Koval M, Schug WJ, Isakson BE (2023) Pharmacology of pannexin channels. Curr Opin Pharmacol 69:102359. https:\/\/doi.org\/10.1016\/j.coph.2023.102359","journal-title":"Curr Opin Pharmacol"},{"issue":"8","key":"7035_CR45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.2018.11406","volume":"320","author":"HR Kranzler","year":"2018","unstructured":"Kranzler HR, Soyka M (2018) Diagnosis and pharmacotherapy of alcohol use disorder: a review. JAMA 320(8):815\u2013824. https:\/\/doi.org\/10.1001\/jama.2018.11406","journal-title":"JAMA"},{"issue":"6","key":"7035_CR46","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/HYPERTENSIONAHA.110.159459","volume":"57","author":"AW Krug","year":"2011","unstructured":"Krug AW, Pojoga LH, Williams GH, Adler GK (2011) Cell membrane\u2013associated mineralocorticoid receptors? Hypertension 57(6):1019\u20131025. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.159459","journal-title":"Hypertension"},{"key":"7035_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.alcohol.2017.06.002","volume":"65","author":"M Lainiola","year":"2017","unstructured":"Lainiola M, Linden AM (2017) Alcohol intake in two different mouse drinking models after recovery from the lipopolysaccharide-induced sickness reaction. Alcohol 65:1\u201310. https:\/\/doi.org\/10.1016\/j.alcohol.2017.06.002","journal-title":"Alcohol"},{"issue":"5","key":"7035_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.alcohol.2008.03.128","volume":"42","author":"L Leggio","year":"2008","unstructured":"Leggio L, Ferrulli A, Cardone S, Miceli A, Kenna GA, Gasbarrini G, Swift RM, Addolorato G (2008) Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study. Alcohol 42(5):375\u2013381. https:\/\/doi.org\/10.1016\/j.alcohol.2008.03.128","journal-title":"Alcohol"},{"issue":"13","key":"7035_CR49","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1021\/acschemneuro.2c00326","volume":"13","author":"AH L\u00e9k\u00f3","year":"2022","unstructured":"L\u00e9k\u00f3 AH, McGinn MA, Farokhnia M (2022) The mineralocorticoid receptor: an emerging pharmacotherapeutic target for alcohol use disorder? ACS Chem Neurosci 13(13):1832\u20131834. https:\/\/doi.org\/10.1021\/acschemneuro.2c00326","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"7035_CR50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1677\/joe.0.0840371","volume":"84","author":"J Levy","year":"1980","unstructured":"Levy J, Burshell A, Marbach M, Afllalo L, Glick SM (1980) Interaction of spironolactone with oestradiol receptors in cytosol. J Endocrinol 84(3):371\u2013379. https:\/\/doi.org\/10.1677\/joe.0.0840371","journal-title":"J Endocrinol"},{"issue":"2","key":"7035_CR51","first-page":"459","volume":"35","author":"W Losert","year":"1985","unstructured":"Losert W, Casals-Stenzel J, Buse M (1985) Progestogens with antimineralocorticoid activity. Arzneimittelforschung 35(2):459\u2013471","journal-title":"Arzneimittelforschung"},{"key":"7035_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pbb.2018.07.011","volume":"175","author":"VH Makhijani","year":"2018","unstructured":"Makhijani VH, Van Voorhies K, Besheer J (2018) The mineralocorticoid receptor antagonist spironolactone reduces alcohol self-administration in female and male rats. Pharmacol Biochem Behav 175:10\u201318. https:\/\/doi.org\/10.1016\/j.pbb.2018.07.011","journal-title":"Pharmacol Biochem Behav"},{"key":"7035_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108337","volume":"181","author":"VH Makhijani","year":"2020","unstructured":"Makhijani VH, Irukulapati P, Van Voorhies K, Fortino B, Besheer J (2020) Central amygdala mineralocorticoid receptors modulate alcohol self-administration. Neuropharmacology 181:108337. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108337","journal-title":"Neuropharmacology"},{"key":"7035_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108510","volume":"188","author":"MA McGinn","year":"2021","unstructured":"McGinn MA, Tunstall BJ, Schlosburg JE, Gregory-Flores A, George O, de Guglielmo G, Mason BJ, Hunt HJ, Koob GF, Vendruscolo LF (2021) Glucocorticoid receptor modulators decrease alcohol self-administration in male rats. Neuropharmacology 188:108510. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108510","journal-title":"Neuropharmacology"},{"issue":"3","key":"7035_CR55","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1210\/en.2004-1130","volume":"146","author":"L Michea","year":"2005","unstructured":"Michea L, Delpiano AM, Hitschfeld C, Lobos L, Lavandero S, Marusic ET (2005) Eplerenone blocks nongenomic effects of aldosterone on the Na+\/H+ exchanger, intracellular Ca2\u2009+\u2009levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology 146(3):973\u2013980. https:\/\/doi.org\/10.1210\/en.2004-1130","journal-title":"Endocrinology"},{"key":"7035_CR56","unstructured":"National Survey on Drug Use and Health (2024)"},{"key":"7035_CR57","unstructured":"NIAAA (2025) Understanding alcohol use disorder"},{"key":"7035_CR58","unstructured":"NSDUH (2024) https:\/\/www.samhsa.gov\/data\/report\/2024-nsduh-detailed-tables"},{"issue":"4","key":"7035_CR59","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/clpt.1985.206","volume":"38","author":"HW Overdiek","year":"1985","unstructured":"Overdiek HW, Hermens WA, Merkus FW (1985) New insights into the pharmacokinetics of spironolactone. Clin Pharmacol Ther 38(4):469\u2013474. https:\/\/doi.org\/10.1038\/clpt.1985.206","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"7035_CR60","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41386-021-01117-z","volume":"46","author":"VA Palzes","year":"2021","unstructured":"Palzes VA, Farokhnia M, Kline-Simon AH, Elson J, Sterling S, Leggio L, Weisner C, Chi FW (2021) Effectiveness of spironolactone dispensation in reducing weekly alcohol use: a retrospective high-dimensional propensity score-matched cohort study. Neuropsychopharmacology 46(12):2140\u20132147. https:\/\/doi.org\/10.1038\/s41386-021-01117-z","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"7035_CR61","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0022-3956(00)00035-2","volume":"34","author":"PD Patel","year":"2000","unstructured":"Patel PD, Lopez JF, Lyons DM, Burke S, Wallace M, Schatzberg AF (2000) Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res 34(6):383\u2013392. https:\/\/doi.org\/10.1016\/s0022-3956(00)00035-2","journal-title":"J Psychiatr Res"},{"issue":"3","key":"7035_CR62","doi-asserted-by":"publisher","first-page":"362","DOI":"10.15288\/jsad.2021.82.362","volume":"82","author":"ME Patrick","year":"2021","unstructured":"Patrick ME, Evans-Polce RJ, Parks MJ, Terry-McElrath YM (2021) Drinking intensity at age 29\/30 as a predictor of alcohol use disorder symptoms at age 35 in a national sample. J Stud Alcohol Drug 82(3):362\u2013367. https:\/\/doi.org\/10.15288\/jsad.2021.82.362","journal-title":"J Stud Alcohol Drug"},{"key":"7035_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105427","volume":"154","author":"CL Pince","year":"2023","unstructured":"Pince CL, Whiting KE, Wang T, L\u00e9k\u00f3 AH, Farinelli LA, Cooper D, Farokhnia M, Vendruscolo LF, Leggio L (2023) Role of aldosterone and mineralocorticoid receptor (MR) in addiction: a scoping review. Neurosci Biobehav Rev 154:105427. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105427","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"7035_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.physbeh.2004.10.007","volume":"84","author":"JS Rhodes","year":"2005","unstructured":"Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC (2005) Evaluation of a simple model of ethanol drinking to intoxication in C57BL\/6J mice. Physiol Behav 84(1):53\u201363. https:\/\/doi.org\/10.1016\/j.physbeh.2004.10.007","journal-title":"Physiol Behav"},{"key":"7035_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109643","volume":"238","author":"RS Richardson","year":"2023","unstructured":"Richardson RS, Sulima A, Rice KC, Kucharczk JA, Janda KD, Nisbett KE, Koob GF, Vendruscolo LF, Leggio L (2023) Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice. Neuropharmacology 238:109643. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109643","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"7035_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0169-328x(98)00161-2","volume":"61","author":"AC Robson","year":"1998","unstructured":"Robson AC, Leckie CM, Seckl JR, Holmes MC (1998) 11 beta-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Brain Res Mol Brain Res 61(1\u20132):1\u201310. https:\/\/doi.org\/10.1016\/s0169-328x(98)00161-2","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"7035_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-2999(94)90608-4","volume":"256","author":"G Saab","year":"1994","unstructured":"Saab G, Robertson JM, Harding S, Grupp LA (1994) Adrenalectomy does not modify the suppressive effect of angiotensin II on voluntary ethanol drinking in rats. Eur J Pharmacol 256(1):1\u20137. https:\/\/doi.org\/10.1016\/0014-2999(94)90608-4","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"7035_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.13","volume":"6","author":"PP Sanna","year":"2016","unstructured":"Sanna PP, Kawamura T, Chen J, Koob GF, Roberts AJ, Vendruscolo LF, Repunte-Canonigo V (2016) 11\u03b2-hydroxysteroid dehydrogenase inhibition as a new potential therapeutic target for alcohol abuse. Transl Psychiatry 6(3):e760\u2013e760. https:\/\/doi.org\/10.1038\/tp.2016.13","journal-title":"Transl Psychiatry"},{"issue":"4","key":"7035_CR69","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/clc.20324","volume":"31","author":"A Struthers","year":"2008","unstructured":"Struthers A, Krum H, Williams GH (2008) A comparison of the aldosterone-blocking agents eplerenone and spironolactone. Clin Cardiol 31(4):153\u2013158. https:\/\/doi.org\/10.1002\/clc.20324","journal-title":"Clin Cardiol"},{"issue":"5","key":"7035_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108488","volume":"301","author":"T Sueyoshi","year":"2025","unstructured":"Sueyoshi T, Petrillo MG, Jewell CM, Bortner CD, Perera L, Xu X, Aguayo FI, Diaz-Jimenez D, Robinson AG, Cook ME, Oakley RH, Cidlowski JA (2025) Molecular interactions of glucocorticoid and mineralocorticoid receptors define novel transcription and biological functions. J Biol Chem 108488. https:\/\/doi.org\/10.1016\/j.jbc.2025.108488","journal-title":"J Biol Chem"},{"issue":"9","key":"7035_CR71","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1210\/me.2005-0089","volume":"19","author":"L Pascual-Le Tallec","year":"2005","unstructured":"Pascual-Le Tallec L, Lombes M (2005) The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol Endocrinol 19(9):2211\u20132221. https:\/\/doi.org\/10.1210\/me.2005-0089","journal-title":"Mol Endocrinol"},{"key":"7035_CR72","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.psyneuen.2014.10.022","volume":"52","author":"F ter Heegde","year":"2015","unstructured":"ter Heegde F, De Rijk RH, Vinkers CH (2015) The brain mineralocorticoid receptor and stress resilience. Psychoneuroendocrinology 52:92\u2013110. https:\/\/doi.org\/10.1016\/j.psyneuen.2014.10.022","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"7035_CR73","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/alcalc\/agz054","volume":"54","author":"BJ Tunstall","year":"2019","unstructured":"Tunstall BJ, Lorrai I, McConnell SA, Gazo KL, Zallar LJ, de Guglielmo G, Hoang I, Haass-Koffler CL, Repunte-Canonigo V, Koob GF, Vendruscolo LF, Sanna PP (2019) Probenecid reduces alcohol drinking in rodents. Is Pannexin1 a novel therapeutic target for alcohol use disorder? Alcohol Alcohol 54(5):497\u2013502. https:\/\/doi.org\/10.1093\/alcalc\/agz054","journal-title":"Alcohol Alcohol"},{"issue":"8","key":"7035_CR74","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1172\/JCI79828","volume":"125","author":"LF Vendruscolo","year":"2015","unstructured":"Vendruscolo LF, Estey D, Goodell V, Macshane LG, Logrip ML, Schlosburg JE, McGinn MA, Zamora-Martinez ER, Belanoff JK, Hunt HJ, Sanna PP, George O, Koob GF, Edwards S, Mason BJ (2015) Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals. J Clin Invest 125(8):3193\u20133197. https:\/\/doi.org\/10.1172\/JCI79828","journal-title":"J Clin Invest"},{"key":"7035_CR75","doi-asserted-by":"crossref","unstructured":"Vendruscolo LF, Koob GF, Zorrilla EP (2023) Alcohol Use Disorder: Stress, Negative Reinforcement, and Negative Urgency. In: Mueller S, Heilig M (eds) Alcohol and Alcohol-related Diseases. Springer International Publishing, pp 687\u2013719","DOI":"10.1007\/978-3-031-32483-3_36"},{"issue":"6","key":"7035_CR76","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","volume":"7","author":"TT Wager","year":"2016","unstructured":"Wager TT, Hou X, Verhoest PR, Villalobos A (2016) Central nervous system multiparameter optimization desirability: application in drug discovery. ACS Chem Neurosci 7(6):767\u2013775. https:\/\/doi.org\/10.1021\/acschemneuro.6b00029","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"7035_CR77","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1085\/jgp.201310966","volume":"141","author":"J Wang","year":"2013","unstructured":"Wang J, Jackson DG, Dahl G (2013) The food dye FD&C blue 1 is a selective inhibitor of the ATP release channel Panx1. J Gen Physiol 141(5):649\u2013656. https:\/\/doi.org\/10.1085\/jgp.201310966","journal-title":"J Gen Physiol"},{"issue":"4","key":"7035_CR78","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1530-0277.1993.tb00851.x","volume":"17","author":"DA Wigle","year":"1993","unstructured":"Wigle DA, Pang SC, Radakovic NN, Sarda IR, Watson JD, Roy RN, Flynn TG (1993) Chronic ethanol ingestion modifies the renin-aldosterone axis independent of alterations in the regulation of atrial natriuretic peptide. Alcohol Clin Exp Res 17(4):841\u2013846. https:\/\/doi.org\/10.1111\/j.1530-0277.1993.tb00851.x","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"7035_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00424-008-0615-1","volume":"458","author":"L Wildling","year":"2009","unstructured":"Wildling L, Hinterdorfer P, Kusche-Vihrog K, Treffner Y, Oberleithner H (2009) Aldosterone receptor sites on plasma membrane of human vascular endothelium detected by a mechanical nanosensor. Pfl\u00fcgers Archiv - Eur J Physiol 458(2):223\u2013230. https:\/\/doi.org\/10.1007\/s00424-008-0615-1","journal-title":"Pfl\u00fcgers Archiv - Eur J Physiol"},{"issue":"9","key":"7035_CR80","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax4043","volume":"5","author":"K Witkiewitz","year":"2019","unstructured":"Witkiewitz K, Litten RZ, Leggio L (2019) Advances in the science and treatment of alcohol use disorder. Sci Adv 5(9):eaax4043. https:\/\/doi.org\/10.1126\/sciadv.aax4043","journal-title":"Sci Adv"},{"key":"7035_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54737-6","volume":"15","author":"LJ Zallar","year":"2024","unstructured":"Zallar LJ, Rivera-Irizarry JK, Hamor PU, Pigulevskiy I, Rico Rozo A-S, Mehanna H, Liu D, Welday JP, Bender R, Asfouri JJ, Levine OB, Skelly MJ, Hadley CK, Fecteau KM, Nelson S, Miller J, Ghazal P, Bellotti P, Singh A, Hollmer LV, Erikson DW, Geri J, Pleil KE (2024) Rapid nongenomic estrogen signaling controls alcohol drinking behavior in mice. Nat Commun 15:10725. https:\/\/doi.org\/10.1038\/s41467-024-54737-6","journal-title":"Nat Commun"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07035-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07035-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07035-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:58:45Z","timestamp":1773039525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07035-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":81,"alternative-id":["7035"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07035-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}